Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...

Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...

Researchers have developed new AI approach to select chemical compounds potentially effective for treating tuburculosis.

By restoring the body’s ability to produce KLK1, therapies are emerging for preeclampsia moms and for acute ischemic stroke ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Tests in mice with severe infections showed that the nanodiscs reduced the amount of fungus in major organs and improved survival rates.

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...

Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...

Plant-based protein expression systems could help biopharma build production capacity in the Global South, according to new ...

Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.